Minority M184V variants in women exposed to 3TC/FTC‐containing lopinavir‐ritonavir (LPVr) regimens in pregnancy
S Surah(Guy's and St Thomas' NHS Foundation Trust), Annemiek de Ruiter(ViiV Healthcare (Spain)), Mary‐Claire Hanlon(Guy's and St Thomas' NHS Foundation Trust), Sinead Costelloe(Guy's and St Thomas' NHS Foundation Trust), Jane Mullen(St Thomas' Hospital), Siobhan O’Shea(St Thomas' Hospital), I. L. Chrystie(St Thomas' Hospital), GP Taylor(St Mary's Hospital)
Cited by 0
Related Papers
Prevalence of Kaposi's sarcoma associated herpesvirus infection measured by antibodies to recombinant capsid protein and latent immunofluorescence antigen
|The Lancet|1996|631
Earlier initiation of ART and further decline in mother-to-child HIV transmission rates, 2000–2011
|AIDS|2014|397
Treatment of tuberculosis in HIV-infected persons in the era of highly active antiretroviral therapy
|AIDS|2002|359
A Review of Long-Term Toxicity of Antiretroviral Treatment Regimens and Implications for an Aging Population
|Infectious Diseases and Therapy|2018|197